TickerFacts.

MaxCyte, Inc. (MXCT): Operating Income

Annual figures by period end, from SEC filings.

-$51.90M
Year ended 2025-12-31
-$41.79M
Trailing 12 months to 2026-06-30
2019-12-31: -$12.42M2020-12-31: -$11.06M2021-12-31: -$18.19M2022-12-31: -$27.36M2023-12-31: -$48.30M2024-12-31: -$51.20M2025-12-31: -$51.90M-$51.90M
2019-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$51.90Mn/m2026-03-25, From 2025-01-01
2024-12-31-$51.20Mn/m2026-03-25, From 2024-01-01
2023-12-31-$48.30Mn/m2025-03-11, From 2023-01-01
2022-12-31-$27.36Mn/m2024-03-12, From 2022-01-01
2021-12-31-$18.19Mn/m2023-03-15, From 2021-01-01
2020-12-31-$11.06Mn/m2022-03-22, From 2020-01-01
2019-12-31-$12.42Mn/a2022-03-22, From 2019-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
MaxCyte, Inc. (MXCT)2025-12-31-$51.90Mn/m
OmniAb, Inc. (OABI)2025-12-31-$68.97Mn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$10.33Mn/m
NRC Health (NRC)2025-12-31$22.59M-35.8%
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$10.57Mn/m
Absci Corp (ABSI)2025-12-31-$120.32Mn/m
iSpecimen Inc. (ISPC)2025-12-31-$8.98Mn/m
OneMedNet Corp (ONMD)2025-12-31-$9.67Mn/m
Medpace Holdings, Inc. (MEDP)2025-12-31$534.93M+19.7%

Compare MXCT, OABI, FOXO, NRC side by side · Screen every company in Services-Commercial Physical & Biological Research ↗